NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/04/2021
Voltar para busca
Dado oficial do USPTO
ERREGIERRE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
27
Atualização mais recente
09/04/2021
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 42
Data de depósito
01/09/2008
Data de registro
28/04/2009
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/05/2019
Última transação
08/05/2019
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
09
Localização do titular
SAN PAOLO D'ARGON (BG), IT
Examinador
MICHELI, ANGELA M
Unidade examinadora
L10
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
ERREGIERRE S.P.A.
ERREGIERRE S.P.A.
Representantes
Lawrence E. Abelman Abelman Frayne & Schwab
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for industrial purposeschemicals for use in the manufacture of principle active ingredientschemicals for use in industrychemicals for use in the biochemical and chemical industrychemicals for use in biotechnological manufacturing processeschemicals used in industry
Classe 5
Antiarrhythmicsanticoagulantsanticonvulsantsantidepressantsantidiabetic preparationsantiemeticsantifungal creams for medical useantihistaminesantihypertensivesantipyretic analgesicsanti-diabetic pharmaceuticalsanti-diabetic preparationsanti-inflammatoriesanti-inflammatory and antipyretic preparationsanti-inflammatory gelsanti-inflammatory ointmentsappetite suppressantsbeta blockersbronchial dilatorsbronchodilatorscardiovascular pharmaceuticalscardiovascular treatment preparationscholesterol reducersdermatological pharmaceutical productsdermatologicalseye dropsfungicides for medical usemuscle relaxantsnausea treatment preparationsophthalmic preparationsophthalmologic preparationsophthalmological preparationspharmaceutical preparationsanticoagulantspharmaceutical preparationsantidepressantspharmaceutical preparationsappetite suppressantspharmaceutical preparations for the treatment of heart rhythm disorderspharmaceutical preparations active on the central nervous systempharmaceutical preparations and substances for the treatment of gastro-intestinal diseasespharmaceutical preparations for inhalation for the treatment of pulmonary hypertensionpharmaceutical preparations for treating allergic rhinitis and asthmapharmaceutical preparations for treating diabetespharmaceutical preparations for use in dermatologypharmaceutical preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary systemfor the treatment of inflammatory disordersfor use in dermatologyoncologyhematology and in tissue and organ transplantationin ophtalmology and for gastroenterological disorderspharmaceutical preparations for skin carepharmaceutical products for opthalmological usepharmaceutical products for treating respiratory diseases and asthmapharmaceutical skin lotionsvaginal preparationsantifungals
Classe 42
Chemical analysischemical laboratorieschemical researchdevelopment of new technology for others in the field of custom synthesisdevelopment of pharmaceutical preparations and medicineslaboratory research in the field of chemistrymedical and scientific researchconducting clinical trialsmedical and scientific research in the field of medical imagingproduct developmentproduct researchproduct research and developmentresearch and development for new products for othersresearch and development of new productsresearch in the field of chemistryresearch on the subject of pharmaceuticalstestinginspection or research of pharmaceuticalscosmetics or foodstuff
Publicações
Histórico de despachos e eventos da marca no USPTO.
27 publicações encontradas
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
31/01/2020
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
08/01/2020
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
08/05/2019
71AG
REGISTERED-SEC.71 ACCEPTED
08/05/2019
ES71
TEAS SECTION 71 RECEIVED
29/04/2019
RNWL
INTERNATIONAL REGISTRATION RENEWED
20/09/2018
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
28/04/2018
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
21/04/2017
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
01/06/2016
INPC
INVALIDATION PROCESSED
01/06/2016
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
29/05/2016
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
29/09/2015
71AG
REGISTERED-SEC.71 ACCEPTED
29/09/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
29/09/2015
ES71
TEAS SECTION 71 RECEIVED
20/08/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
28/04/2009
PUBO
PUBLISHED FOR OPPOSITION
10/02/2009
NPUB
NOTICE OF PUBLICATION
21/01/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/01/2009
ALIE
ASSIGNED TO LIE
03/01/2009
MAFR
APPLICATION FILING RECEIPT MAILED
20/12/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/12/2008
DOCK
ASSIGNED TO EXAMINER
16/12/2008
NWAP
NEW APPLICATION ENTERED
16/12/2008
LIMS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
15/12/2008
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/12/2008
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ERREGIERRE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.